| Title : First in human study with a prodrug of galantamine: Improved benefit-risk ratio? - Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| Author(s) : Baakman AC , t Hart E , Kay DG , Stevens J , Klaassen ES , Maelicke A , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 2 :13 , 2016 |
| Abstract : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| ESTHER : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedSearch : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedID: 29067291 |
Baakman AC, t Hart E, Kay DG, Stevens J, Klaassen ES, Maelicke A, Groeneveld GJ (2016)
First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
Alzheimers Dement (N Y)
2 :13
Baakman AC, t Hart E, Kay DG, Stevens J, Klaassen ES, Maelicke A, Groeneveld GJ (2016)
Alzheimers Dement (N Y)
2 :13